Learn how to facilitate growth while ensuring that your plans are supported by sound financial data and effective company execution.

Named by FORTUNE magazine as 2013’s fastest-growing company, Jazz Pharmaceuticals is a specialty biopharmaceutical company with a product portfolio that includes the highly successful XYREM®, a medication used to treat symptoms associated with narcolepsy.

Find out how Jazz Pharmaceuticals’ implementation of a cloud-based EPM suite has enabled it to achieve rapid growth and multiple acquisitions without putting undue strain on its financial team or compromising its data analysis capabilities.

Please fill the below form to download

Download